Acadian Asset Management
ABEO icon

Acadian Asset Management’s Abeona Therapeutics ABEO Stock Holding History

Acadian Asset Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,634
Closed -$91K – 1729
2024
Q1 		$91K Buy
+12,634
New +$80.1K ﹤0.01% 1303
2022
Q1 		– Sell
-9,467
Closed -$78K – 1619
2021
Q4 		$78K Buy
+9,467
New +$174K ﹤0.01% 1421
2021
Q1 		– Sell
-603
Closed -$24K – 2031
2020
Q4 		$24K Buy
+603
New +$20.5K ﹤0.01% 2118

Other funds holding ABEO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Acadian Asset Management's ABEO Position: Q2 2024 in Review

Acadian Asset Management sold out of Abeona Therapeutics (ABEO) in Q2 2024, closing a stake of 12,634 shares — an estimated $91K sold.

Acadian Asset Management first reported a position in ABEO in Q4 2020 and held it in 3 quarters. The position peaked at $91K in Q1 2024. 48 funds tracked by Wall St. Rank hold ABEO as of Q2 2024.

  • Acadian Asset Management reported no remaining Abeona Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Acadian Asset Management sold 12,634 Abeona Therapeutics shares in Q2 2024, an estimated $91K.
  • Acadian Asset Management first reported a position in Abeona Therapeutics in Q4 2020 and held it in 3 quarters.
  • Acadian Asset Management's Abeona Therapeutics position peaked at $91K in Q1 2024.
  • 48 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2024.

Based on Acadian Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.